• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Therapy

Category

All
  • Pharma News
  • Health of Tomorrow
  • Opinion
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical Practice
  • Corona
  • Cancer trials
  • Healthy Living
  • Medical Research
  • Art on View
  • Viewpoints
  • Therapy
  • Health Innovation
  • Podcasts
  • Editor's pick
  • Publishing News
  • Special
  • BSMO Meeting 2021
  • Covid-19
  • EADO 2021

Therapy

Pembrolizumab as post-nephrectomy adjuvant therapy reduces the risk of recurrence in patients ...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • The Belgian Virtual Tumourbank: Residual tumour samples with high quality data
  • Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
  • Individualising radiation therapy decisions in breast cancer patients based on tumour-infiltrating lymphocytes and genomic biomarkers
  • Early-onset cancers: Incidence trends in Belgium, 2004–2020
  • Improving dysphagia care in head and neck cancer patients treated with radiotherapy
  • Journal Scan
  • New oncology reimbursements in Belgium
Therapy

Twenty-year benefit from adjuvant goserelin and tamoxifen in premenopausal patients with breas...

Read more
Therapy

MEK inhibitor trametinib is the new standard of care for patients with low-grade serous ovaria...

Read more
Therapy

Microsatellite instability and poor response to chemotherapy in gastric cancers

Read more
Therapy

CEMIPLIMAB IMPROVES SURVIVAL OUTCOMES IN CERVICAL CANCER PATIENTS

Read more
Therapy

Immune therapy cleared as first line treatment for metastatic colon cancer

Read more
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023